Actively Recruiting
TriClip CED RWE Study
Led by Abbott Medical Devices · Updated on 2025-08-11
2200
Participants Needed
1
Research Sites
364 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This Coverage with Evidence Development (CED) study evaluates the long-term health outcomes of patients with symptomatic, severe or greater Tricuspid Regurgitation who received a Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) procedure using the TriClip system.
CONDITIONS
Official Title
TriClip CED RWE Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years of age or older at time of implant
- Patients with symptomatic, severe or greater Tricuspid Regurgitation who have received the TriClip system (treatment group) or have not undergone T-TEER (control group)
You will not qualify if you...
- Patients with less than severe Tricuspid Regurgitation
- Patients with a prior history of surgical or transcatheter tricuspid valve replacement
- Patients with a surgical or transcatheter aortic or mitral valve intervention within 90 days prior to index
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Abbott
Santa Clara, California, United States, 95054
Actively Recruiting
Research Team
T
TRICARE
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here